Home » Authors » Mark McCarty

Articles by Mark McCarty

Drum-beat of battle continues in effort to block imaging cuts

Dec. 14, 2006

By Mark McCarty

Radiology scanning fails to win roll-back of payment reductions

Dec. 14, 2006

By Mark McCarty

Radiology scanning fails to win roll-back of payment reductions

Dec. 13, 2006

By Mark McCarty

Off-label use of DES doesn’t alter panel recommendations

Dec. 12, 2006

By Mark McCarty

Panel says data not enough to argue DES riskier than BMS

Dec. 11, 2006

By Mark McCarty

Disability in elderly tailing off as Baby Boomers encroach

Dec. 8, 2006

By Mark McCarty

Schultz mum on whether FDA to seek larger beefed-up trials

Dec. 7, 2006

By Mark McCarty

Medicare Advantage payments become part of flap over Part B

Dec. 6, 2006

By Mark McCarty

Medtronic seeks growth in mid-teens, will spin AED unit

Dec. 5, 2006

By Mark McCarty

Washington roundup: Scientist says master cardiac stem cells no threat to devices

Dec. 1, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 3, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.